BRCA1 and BRCA2 and breast cancer incidence: A review

Annals of Oncology

Volumn 10, Issue SUPPL. 6, 1999, Pages

  Bishop, D Timothy ^a,b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

BRCA1; BRCA2; Inherited susceptibility; Linkage mapping; Penetrance

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; COWDEN SYNDROME; DISEASE ASSOCIATION; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; PEDIGREE ANALYSIS; PENETRANCE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033382686     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_6.S113     Document Type: Conference Paper

References (34)

1. Kuller LH. The etiology of breast cancer - from epidemiology to prevention. Public Health Reviews 1995; 23: 157-213.
2. Claus EB. The genetic epidemiology of cancer. Cancer Surveys 1995; 25: 13-26.
3. Pharoah PD, Day NE, Duffy S et al. Family history and the risk of breast cancer: A systematic review and meta-analysis. International Journal of Cancer 1997; 71: 800-9.
4. Bishop DT, Eby N, Chang-Claude J. Recent Progress in Breast Cancer Genetic Epidemiology. In: Howell A, ed. Endocrine Therapy of Breast Cancer VI. Vol. VI: Springer-Verlag 1994: 3-15.
5. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. American Journal of Epidemiology 1990; 131: 961-72.
6. Li FP, Fraumeni JF, Mulvihill JJ et al. A cancer family syndrome in 24 kindreds. Cancer Research 1988; 48: 5358-62.
7. Malkin D, Li FP, Strong LC et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-8.
8. Starink TM, van der Veen JP, Arwert F et al. The Cowden syndrome: a clinical and genetic study in 21 patients. Clinical Genetics 1986; 29: 222-33.
9. Marsh DJ, Coulon V, Lunetta KL et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Human Molecular Genetics 1998; 7: 507-15.
10. Liaw D, Marsh DJ, Li J et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genetics 1997; 16: 64-7.
11. Hall JM, Lee MK, Newman B et al. Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21. Science 1990; 250: 1684-9.
12. Narod SA, Feuteun J, Lynch HT et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 1991; 338: 82-3.
13. Easton DF, Bishop DT, Ford D et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. American Journal of Human Genetics 1993; 52: 678-701.
14. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
15. Shattuck-Eidens D, McClure M, Simard J et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 1995; 273: 535-41.
16. Stratton MR, Ford D, Neuhasen S et al. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nature Genetics 1994; 7: 103-7.
17. Wooster R, Neuhausen SL, Mangion J et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-90.
18. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378 (Dec 21/28): 789-92.
19. Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-89.
20. Gayther SA, Warren W, Mazoyer S et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genetics 1995; 11: 428-33.
21. Xu CF, Chambers JA, Nicolai H et al. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes, Chromosomes & Cancer 1997; 18: 102-10.
22. Gayther SA, Harrington P, Russell P et al. Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am J Hum Genet 1996; 58: 451-6.
23. Stoppa Lyonnet D. BRCA sequence variations in 160 individuals referred to a breast/ovary family cancer clinic. Am J of Hum Genet 1997; 60: 1021-30.
24. Andersen TI, Børresen A-L, Møller P. A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Hum Genet 1996; 59: 486-7.
25. Johannsson O, Ostermeyer EA, Håkansson S et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in Southern Sweden. Am J Hum Genet 1996; 58: 441-50.
26. Hakansson S, Johannsson O, Johansson U et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet 1997; 60: 1068-78.
27. Newman B. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 1998; 279: 915-21.
28. Malone K. BRCA1 mutations and breast cancer in the general population. JAMA 1998; 279: 922-9.
29. Narod S, Ford D, Devilee P et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet 1995; 56: 254-64.
30. Easton DF, Steele L, Fields P et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997; 61: 120-8.
31. Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi jews. N Eng J Med 1997; 336: 1401-8.
32. Thorlacius S, Struewing JP, Hartge P et al. Population-based study of breast cancer in carriers of BRCA2 mutation. Lancet. 1998; 352: 1337-9.
33. Gayther SA, Mangion J, Russell P et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997; 15: 103-5.
34. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997; 349: 1505-10.